vTv Therapeutics (VTVT) EBT Margin Growth (3y) (2017 - 2024)

vTv Therapeutics (VTVT) EBT Margin Growth (3y) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,237.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -408.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 7.93 Mn
Mar 31, 2024 861.00
Dec 31, 2022 3.06 Mn
Jun 30, 2022 -4.52 Mn
Mar 31, 2022 -2,884.00
Dec 31, 2021 -10.53 Mn
Sep 30, 2021 1,260.00
Jun 30, 2021 -896,450.00
Mar 31, 2021 -11,795.00
Dec 31, 2020 594,443.00
Sep 30, 2020 5.02 Mn
Mar 31, 2020 -4.19 Mn
Dec 31, 2019 -6.22 Mn
Sep 30, 2019 -3.90 Mn
Jun 30, 2019 775,703.00
Mar 31, 2019 316,339.00
Dec 31, 2018 484,188.00
Sep 30, 2018 732,686.00
Jun 30, 2018 908,551.00
Mar 31, 2018 1.91 Mn